Genomics
-
Fujifilm Diosynth Biotechnologies Breaks Ground on Advanced Therapies Innovation Center
9-1-2020Fujifilm Diosynth Biotechnologies broke ground in August of 2020 on the $55 million Advanced Therapies Innovation Center in College Station, Texas.
-
Codiak BioSciences Installs G-CON PODs in Clinical Manufacturing Facility
8-19-2020Codiak BioSciences is constructing a 12,000-sf clinical manufacturing center in Lexington, Mass. The project includes the build-out of a leased lab and office building to create a GMP facility for the production of exosome therapeutics.
-
CRISPR Therapeutics Expands Research and Manufacturing Facilities
8-10-2020CRISPR Therapeutics signed a full-building lease in July of 2020 for a 263,500-sf facility in Boston's Seaport district.
-
DiNAQOR AG Completes Gene Therapy R&D Center
7-31-2020DiNAQOR AG completed construction in July of 2020 on a 9,687-sf R&D center in Schlieren, Switzerland.
-
Carter Winstanley Plans Bioscience Research Building in New Haven
7-29-2020Carter Winstanley is planning to build a $100 million bioscience research building in New Haven, Conn.
-
University Hospital Hamburg-Eppendorf Plans Center for Translational Immunology
7-15-2020University Hospital Hamburg-Eppendorf is planning to build a 193,000-sf translational medicine hub in Hamburg, Germany.
-
Genomic Partnership Wales Designs Research Facility
6-5-2020Genomic Partnership Wales is planning to construct a research facility in Cardiff in the United Kingdom to accelerate the development of pharmaceutical therapies.
-
VACUUBRAND Offers Continuing Education Courses Approved by AIA & GBCI
4-15-2020VACUUBRAND is offering continuing education courses approved by the American Institute of Architects and Green Business Certification Inc.
-
Audentes Plans Gene Therapy Manufacturing Facility
3-7-2020Audentes Therapeutics is planning to construct a $109 million gene therapy manufacturing facility in Sanford, N.C. The 135,000-sf project will support the production of genetic medicines based on adeno-associated virus vectors for the treatment of rare neuromuscular diseases.
